4D Molecular Therapeutics (FDMT) Q1 2025 Earnings

28FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.89
-0.8
-0.72
-0.63

Details

Expected EPS
-0.835455
Actual EPS
-0.89
Surprise EPS
-0.05
Surprise Percent
+6.53%

Description

4D Molecular Therapeutics (FDMT) has reported earnings of -0.89 per share for Q1 2025.

0 Comments

Share your thoughts